Global Molecular Diagnostics Market 2016-2020

分子診断の世界市場2016-2020

◆タイトル:Global Molecular Diagnostics Market 2016-2020
◆商品コード:IRTNTR8570
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年4月18日
◆ページ数:64
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、分子診断の世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、医療費償還シナリオ、市場動向、競争状況などの情報をお届けいたします。

About Molecular Diagnostics
The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market.

Technavio’s analysts forecast the global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global molecular diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of equipment such as automated real-time PCR, mass spectroscopy, and DNA sequencing and DNA microarray diagnostic devices, consumables, and reagents is considered.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Molecular Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• Hologic Inc.
• Qiagen
• Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.)
• Siemens Healthcare GmbH

[Other prominent vendors]
• AsuraGen
• Ahram Biosystem
• Analytik Jena
• BD
• Bio-Rad
• EKF Molecular Diagnostics
• EMD Millipore
• HTG Molecular
• InBios International
• Maxim Biomedical
• Mindray
• Myriad Genetics
• Ortho Clinical Diagnostics
• Ras Lifesciences
• Trivitron Healthcare
• ThermoFisher Scientific

[Market driver]
• Key to cost-effective diagnosis of cancer
• For a full, detailed list, view our report

[Market challenge]
• Reimbursement issues
• For a full, detailed list, view our report

[Market trend]
• Growth of theranostics
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Companion diagnostics: Promising business model
• Reimbursement scenario

PART 06: Perspective of LDTs in US
• Requirement of regulatory framework
• Post implementation scenario

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by application
• Global molecular diagnostics market by infectious disease testing
• Global molecular diagnostics market by oncological testing
• Global molecular diagnostics market by blood testing
• Global molecular diagnostics market by genetic testing
• Global molecular diagnostics market by tissue typing

PART 09: Geographical segmentation
• Molecular diagnostics market in Americas
• Molecular diagnostics market in EMEA
• Molecular diagnostics market in APAC

PART 10: Market drivers
• Key to cost-effective diagnosis of cancer
• Development of molecular POCT
• Increase in investments in genomics and proteomics research

PART 11: Impact of drivers

PART 12: Market challenges
• Reimbursement issues
• Threat of low-cost products
• Issues with quality control and cold chain management
• Ethical issues associated with DTC genetic testing

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Growth of theranostics
• Development of NGS technology and DNA arrays
• Increase in partnerships
• Development of personalized medicine

PART 15: Vendor landscape
• Abbott Diagnostics
• Hologic
• Qiagen
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Examples of approved companion diagnostics
Exhibit 03: Companion diagnostics coverage in the US
Exhibit 04: Global molecular diagnostics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global molecular diagnostics market by application 2015
Exhibit 07: Global molecular diagnostics market by infectious disease testing 2015-2020 ($ billions)
Exhibit 08: Global molecular diagnostic market by oncological testing 2015-2020 ($ billions)
Exhibit 09: Global molecular diagnostics market by blood testing 2015-2020 ($ billions)
Exhibit 10: Global molecular diagnostics market by genetic testing 2015-2020 ($ billions)
Exhibit 11: Global molecular diagnostics market by tissue typing 2015-2020 ($ millions)
Exhibit 12: Segmentation of global molecular diagnostics market by geography 2015
Exhibit 13: Molecular diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 14: Molecular diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 15: Molecular diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Global molecular diagnostics market by vendors 2014 and 2015
Exhibit 19: Key molecular diagnostic product launches by Roche and Qiagen 2015
Exhibit 20: Key takeaways: Abbott Diagnostics
Exhibit 21: Key takeaways: Hologic
Exhibit 22: Key takeaways: Qiagen
Exhibit 23: Key takeaways: Roche Diagnostics
Exhibit 24: Key takeaways: Siemens Healthcare



【掲載企業】

Abbott Laboratories, Hologic Inc., Qiagen, Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.), Siemens Healthcare GmbH, AsuraGen, Ahram Biosystem, Analytik Jena, BD, Bio-Rad, EKF Molecular Diagnostics, EMD Millipore, HTG Molecular, InBios International, Maxim Biomedical, Mindray, Myriad Genetics, Ortho Clinical Diagnostics, Ras Lifesciences, Trivitron Healthcare, ThermoFisher Scientific.

【資料のキーワード】

分子診断、分子診断装置、感染症検査、 腫瘍検査、血液検査、遺伝子検査、組織適合試験

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[分子診断の世界市場2016-2020] (Global Molecular Diagnostics Market 2016-2020 / IRTNTR8570)販売に関する免責事項
[分子診断の世界市場2016-2020] (Global Molecular Diagnostics Market 2016-2020 / IRTNTR8570)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆